Civic Intelligence

The Biosimilars Forum

990 • Fiscal year 2015 • EIN 81-0762544

Jan 01, 2015 to Dec 31, 2015

Organization ProfileWWW.BIOSIMILARSFORUM.ORG
Ashburn, VA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

92nd percentile

0.75x

Higher debt load relative to assets than 92% of similar nonprofits.

2015 filings • 501(c)6 • $1M-$5M nonprofits • Source year 2015

Liabilities / Revenue

95th percentile

1.20x

Higher debt load relative to revenue than 95% of similar nonprofits.

2015 filings • 501(c)6 • $1M-$5M nonprofits • Source year 2015

Net Margin

96th percentile

40%

Higher net margin than 96% of similar nonprofits.

2015 filings • 501(c)6 • $1M-$5M nonprofits • Source year 2015

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2015

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2015

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2015

Balance Sheet
Liabilities / Assets92nd percentile

Assets

$2,712,461

No earlier filing loaded for comparison.

Net Assets

$682,611

No earlier filing loaded for comparison.

Liabilities

$2,029,850

No earlier filing loaded for comparison.

Revenue And Expenses
Liabilities / Revenue95th percentileNet Margin96th percentile

Revenue

$1,687,500

No earlier filing loaded for comparison.

Expenses

$1,004,889

No earlier filing loaded for comparison.

Net Income

$682,611

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

Asset GrowthScore unavailable

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$3.0M$2.0M$1.0M$0Assets 2015: $2,712,461Liabilities 2015: $2,029,850Net Assets 2015: $682,6112015Assets 2016: $2,343,073Liabilities 2016: $1,669,164Net Assets 2016: $673,9092016Assets 2017: $2,276,847Liabilities 2017: $1,725,840Net Assets 2017: $551,0072017Assets 2018: $2,282,034Liabilities 2018: $1,400,000Net Assets 2018: $882,0342018Assets 2019: $2,418,083Liabilities 2019: $1,808,167Net Assets 2019: $609,9162019Assets 2020: $2,761,526Liabilities 2020: $1,862,079Net Assets 2020: $899,4472020Assets 2021: $2,503,713Liabilities 2021: $1,801,055Net Assets 2021: $702,6582021Assets 2022: $2,588,857Liabilities 2022: $2,200,420Net Assets 2022: $388,4372022Assets 2023: $2,473,451Liabilities 2023: $2,235,005Net Assets 2023: $238,4462023Assets 2024: $2,722,624Liabilities 2024: $2,347,505Net Assets 2024: $375,1192024

Highlighted filing

2015

Assets$2,712,461
Liabilities$2,029,850
Net Assets$682,611
Open 2015 Filing

Operations Trend

Revenue GrowthScore unavailable

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MRevenue 2015: $1,687,500Expenses 2015: $1,004,889Net Income 2015: $682,6112015Revenue 2016: $1,750,000Expenses 2016: $1,758,702Net Income 2016: -$8,7022016Revenue 2017: $1,575,000Expenses 2017: $1,697,902Net Income 2017: -$122,9022017Revenue 2018: $1,437,020Expenses 2018: $1,105,993Net Income 2018: $331,0272018Revenue 2019: $1,777,994Expenses 2019: $2,050,112Net Income 2019: -$272,1182019Revenue 2020: $2,242,189Expenses 2020: $1,952,658Net Income 2020: $289,5312020Revenue 2021: $2,082,865Expenses 2021: $2,279,654Net Income 2021: -$196,7892021Revenue 2022: $2,105,000Expenses 2022: $2,419,221Net Income 2022: -$314,2212022Revenue 2023: $2,280,500Expenses 2023: $2,430,491Net Income 2023: -$149,9912023Revenue 2024: $2,117,500Expenses 2024: $1,980,827Net Income 2024: $136,6732024

Highlighted filing

2015

Revenue$1,687,500
Expenses$1,004,889
Net Income$682,611
Open 2015 Filing
Filing Detail Status

This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2024)
Jump To
Filing Snapshot
Filing Period
Jan 1, 2015 to Dec 31, 2015
Mission and Program Overview

Mission

The biosimilars forum was incorporated in washington, dc, as a nonprofit organization to advance biosimilars in the united states with the intent of expanding access and availability of biological medicines, and improving health care.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2015 • Form 990Summary only. Only limited summary data is available for this year.

Open filing
Assets
$2,712,461
Liabilities
$2,029,850
Net assets
$682,611
Revenue
$1,687,500
Expenses
$1,004,889
Net income
$682,611
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$2.72$2.35$0.38$2.12$1.98$0.14
2023Detailed filing. Detailed filing data is available for this year.$2.47$2.24$0.24$2.28$2.43$0.15
2022Detailed filing. Detailed filing data is available for this year.$2.59$2.20$0.39$2.11$2.42$0.31
2021Detailed filing. Detailed filing data is available for this year.$2.50$1.80$0.70$2.08$2.28$0.20
2020Detailed filing. Detailed filing data is available for this year.$2.76$1.86$0.90$2.24$1.95$0.29
2019Detailed filing. Detailed filing data is available for this year.$2.42$1.81$0.61$1.78$2.05$0.27
2018Detailed filing. Detailed filing data is available for this year.$2.28$1.40$0.88$1.44$1.11$0.33
2017Detailed filing. Detailed filing data is available for this year.$2.28$1.73$0.55$1.58$1.70$0.12
2016Detailed filing. Detailed filing data is available for this year.$2.34$1.67$0.67$1.75$1.76$0.01
2015Summary only. Only limited summary data is available for this year.$2.71$2.03$0.68$1.69$1.00$0.68